These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 33878831
41. Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test. Eigl S, Prattes J, Reinwald M, Thornton CR, Reischies F, Spiess B, Neumeister P, Zollner-Schwetz I, Raggam RB, Flick H, Buchheidt D, Krause R, Hoenigl M. Int J Antimicrob Agents; 2015 Oct; 46(4):401-5. PubMed ID: 26187363 [Abstract] [Full Text] [Related]
42. Bronchoalveolar lavage fluid and serum 1,3-β-D-glucan testing for invasive pulmonary aspergillosis diagnosis in hematological patients: the role of factors affecting assay performance. Weinbergerova B, Kabut T, Kocmanova I, Lengerova M, Pospisil Z, Kral Z, Mayer J. Sci Rep; 2020 Oct 21; 10(1):17963. PubMed ID: 33087853 [Abstract] [Full Text] [Related]
43. Diagnosis values of Dectin-1 and IL-17 levels in plasma for invasive pulmonary aspergillosis in bronchiectasis. He Q, Li M, Cao J, Zhang M, Feng C. Front Cell Infect Microbiol; 2022 Oct 21; 12():1018499. PubMed ID: 36304934 [Abstract] [Full Text] [Related]
48. Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: a prospective study in pediatric patients. Mohammadi S, Khalilzadeh S, Goudarzipour K, Hassanzad M, Mahdaviani A, Aarabi N, Pourabdollah M, Sigari N. Med Mycol; 2015 Sep 21; 53(7):709-16. PubMed ID: 26229150 [Abstract] [Full Text] [Related]
49. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock. Lahmer T, Rasch S, Schnappauf C, Beitz A, Schmid RM, Huber W. Mycopathologia; 2016 Aug 21; 181(7-8):505-11. PubMed ID: 27142781 [Abstract] [Full Text] [Related]
50. Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a Post Hoc Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis Study. Giacobbe DR, Prattes J, Wauters J, Dettori S, Signori A, Salmanton-García J, Maertens J, Bourgeois M, Reynders M, Rutsaert L, Van Regenmortel N, Lormans P, Feys S, Klimko N, Shadrivova O, Cornely OA, Rautemaa-Richardson R, Koehler P, Lagrou K, Bassetti M, Hoenigl M, ECMM-CAPA Study Group. J Clin Microbiol; 2022 Apr 20; 60(4):e0229821. PubMed ID: 35321555 [Abstract] [Full Text] [Related]
51. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis. Jung J, Kim MY, Chong YP, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH. J Microbiol Immunol Infect; 2018 Dec 20; 51(6):802-809. PubMed ID: 28712819 [Abstract] [Full Text] [Related]
52. Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study. Schroeder M, Simon M, Katchanov J, Wijaya C, Rohde H, Christner M, Laqmani A, Wichmann D, Fuhrmann V, Kluge S. Crit Care; 2016 May 10; 20(1):139. PubMed ID: 27160692 [Abstract] [Full Text] [Related]
53. [Value of serum galactomannan assay in the diagnosis of pediatric invasive pulmonary aspergillosis]. Zhang XY, Zhao SY, Jiang ZF. Zhonghua Er Ke Za Zhi; 2009 Feb 10; 47(2):83-6. PubMed ID: 19573449 [Abstract] [Full Text] [Related]
54. A novel algorithm for diagnosis of invasive pulmonary aspergillosis based on pentraxin 3 gene polymorphisms and its adjusted value among autoimmune diseases patients. Yu Y, Liu C, Zhu C, Zhong H, Gu Z, Xu C, Pan C, Xu Z, Wu Z, Wu W, Lu L. Ann Transl Med; 2022 Jan 10; 10(1):17. PubMed ID: 35242862 [Abstract] [Full Text] [Related]
55. [The value of assay of (1, 3)-β-D-glucan in bronchoalveolar lavage fluid for detection of invasive pulmonary fungal infection in critically ill patients in intensive care unit]. Yang GH, Sheng ZY. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Feb 10; 24(2):90-5. PubMed ID: 22316540 [Abstract] [Full Text] [Related]
56. Utility of Serum and Bronchoalveolar Lavage Fluid Galactomannan in Diagnosis of Chronic Pulmonary Aspergillosis. Sehgal IS, Dhooria S, Choudhary H, Aggarwal AN, Garg M, Chakrabarti A, Agarwal R. J Clin Microbiol; 2019 Mar 10; 57(3):. PubMed ID: 30626661 [Abstract] [Full Text] [Related]
57. Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis. Cao XJ, Li YP, Xie LM, Zhang HL, Qin YS, Guo XG. Biomed Res Int; 2020 Mar 10; 2020():5434589. PubMed ID: 33335924 [Abstract] [Full Text] [Related]
58. The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis. Kono Y, Tsushima K, Yamaguchi K, Kurita N, Soeda S, Fujiwara A, Sugiyama S, Togashi Y, Kasagi S, To M, To Y, Setoguchi Y. Respir Med; 2013 Jul 10; 107(7):1094-100. PubMed ID: 23632100 [Abstract] [Full Text] [Related]
59. Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients. Castillo CG, Kauffman CA, Zhai J, Jiang H, Agozino SM, Miceli MH. Mycoses; 2018 Jan 10; 61(1):4-10. PubMed ID: 28905439 [Abstract] [Full Text] [Related]
60. [The role of galactomannan detection in the diagnosis of invasive pulmonary aspergillosis in critically ill patients]. Shi Y, Liu DW, Long Y, Liu Y, Rui X, Zhou X, Wang XT, DU W. Zhonghua Nei Ke Za Zhi; 2009 Mar 10; 48(3):225-30. PubMed ID: 19576092 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]